US Retail Drug Spending Growth Slowing With No New Sovaldis In Sight
Executive Summary
Rate of growth in prescription drug spending is expected to average 6.7% per year from 2016 through 2025, National Health Expenditures report from CMS projects.
You may also be interested in...
Rx Spending Stands Out In CMS Projections – As Slowing Down
Pharmaceutical industry’s message on overall drug spending trends is getting some timely support from the Center for Medicare and Medicaid Services’ annual national health expenditure projections.
Lilly's Performance Contract For Trulicity Hinges On Head-To-Head Superiority
Price rebates will be based on whether Trulicity is superior to other GLP-1 agonists in lowering A1C blood sugar for Harvard Pilgrim members.
Rx Cost Containment At CareFirst Driven By Physician Incentives
Legal changes that allow more data sharing can encourage value-based contracting, Executive VP-Medical Affairs Blum says